Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients
Authors
Keywords
-
Journal
LEUKEMIA
Volume 29, Issue 11, Pages 2192-2201
Publisher
Springer Nature
Online
2015-07-17
DOI
10.1038/leu.2015.150
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proplatelet generation in the mouse requires PKC -dependent RhoA inhibition
- (2013) G. Gobbi et al. BLOOD
- SH2B3 (LNK)mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F
- (2013) Maya Koren-Michowitz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Safety and Efficacy of KAI-1678— An Inhibitor of Epsilon Protein Kinase C (εPKC)—Versus Lidocaine and Placebo for the Treatment of Postherpetic Neuralgia: A Crossover Study Design
- (2013) Michael J. Cousins et al. PAIN MEDICINE
- A Single-Center, Randomized, Double-Blind, Active, and Placebo-Controlled Study of KAI-1678, a Novel PKC-Epsilon Inhibitor, in the Treatment of Acute Postoperative Orthopedic Pain
- (2013) John E. Moodie et al. PAIN MEDICINE
- Megakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connection
- (2012) N. Papadantonakis et al. BLOOD
- Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?
- (2012) Hans Carl Hasselbalch LEUKEMIA RESEARCH
- Protein Kinase C ε in Hematopoiesis: Conductor or Selector?
- (2012) Giuliana Gobbi et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- PKCε paves the way for prostate cancer
- (2011) Alakananda Basu CELL CYCLE
- Normal and malignant megakaryopoiesis
- (2011) Qiang Wen et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- TRAIL up-regulation must be accompanied by a reciprocal PKCε down-regulation during differentiation of colonic epithelial cell: Implications for colorectal cancer cell differentiation
- (2011) Giuliana Gobbi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
- (2011) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms
- (2011) O Abdel-Wahab et al. LEUKEMIA
- Mutations galore in myeloproliferative neoplasms: Would the real Spartacus please stand up?
- (2011) A Tefferi LEUKEMIA
- In Vitro Megakaryocyte Differentiation and Proplatelet Formation in Ph-Negative Classical Myeloproliferative Neoplasms: Distinct Patterns in the Different Clinical Phenotypes
- (2011) Alessandra Balduini et al. PLoS One
- Genetic and Epigenetic Complexity in Myeloproliferative Neoplasms
- (2011) N. C. P. Cross Hematology-American Society of Hematology Education Program
- Management of Myelofibrosis
- (2011) A. M. Vannucchi Hematology-American Society of Hematology Education Program
- Deletions of the transcription factor Ikaros in myeloproliferative neoplasms
- (2010) R Jäger et al. LEUKEMIA
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- Somatic Mutations ofIDH1andIDH2in the Leukemic Transformation of Myeloproliferative Neoplasms
- (2010) Anthony Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Philadelphia Chromosome–Negative Chronic Myeloproliferative Disease
- (2009) Juergen Thiele AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
- (2009) F. H. Grand et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
- (2009) F. Passamonti et al. BLOOD
- Protein kinase C is involved in the regulation of several calreticulin posttranslational modifications
- (2009) M. Cristina Castañeda-Patlán et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mutations of ASXL1 gene in myeloproliferative neoplasms
- (2009) N Carbuccia et al. LEUKEMIA
- Protein kinases C isozymes are differentially expressed in human breast carcinomas
- (2009) Shadan Ali et al. LIFE SCIENCES
- Protein kinase Cε: an oncogene and emerging tumor biomarker
- (2009) Michael A Gorin et al. Molecular Cancer
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phorbol ester-induced PKC down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation
- (2008) G. Gobbi et al. BLOOD
- Myeloproliferative disorders
- (2008) R. L. Levine et al. BLOOD
- MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
- (2008) P. A. Beer et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search